From Surf Wiki (app.surf) — the open knowledge base
MiR-144
Family of microRNA precursors
Family of microRNA precursors
| Field | Value |
|---|---|
| Name | miR-144 |
| image | Mir-144 SS.png |
| caption | Conserved secondary structure of miR-144 precursor microRNA |
| Symbol | miR-144 |
| AltSymbols | MIR144 |
| Rfam | RF00682 |
| miRBase | MI0000460 |
| miRBase_family | MIPF0000093 |
| RNA_type | miRNA |
| Tax_domain | Mammalia |
| GO | 0035195 |
| SO | 0001244 |
| EntrezGene | 406936 |
| HGNCid | 31531 |
| OMIM | 612070 |
| RefSeq | NR_029685 |
| Chromosome | 17 |
| Arm | q |
| Band | 11.2 |
miR-144 is a family of microRNA precursors found in mammals, including humans. The ~22 nucleotide mature miRNA sequence is excised from the precursor hairpin by the enzyme Dicer. In humans, miR-144 has been characterised as a "common miRNA signature" of a number of different tumours.
GATA4 is thought to activate transcription of the miR-144 microRNA precursor.
Function
miR-144 functions in a cluster with miR-451. This locus regulates the expression of a number of genes whose products are involved in erythropoiesis. One of the identified targets of miR-144 is insulin receptor substrate 1.
Applications
miR-144 has been identified as one of a number of potential miRNA targets which could be used to treat schizophrenia and bipolar affective disorder. It has also been suggested as a potential therapeutic tool to treat ischemic heart disease.
References
References
- (Dec 2001). "microRNAs: tiny regulators with great potential". Cell.
- (Oct 2011). "Human tumor microRNA signatures derived from large-scale oligonucleotide microarray datasets". International Journal of Cancer.
- (Nov 2010). "Synergistic effects of the GATA-4-mediated miR-144/451 cluster in protection against simulated ischemia/reperfusion-induced cardiomyocyte death". Journal of Molecular and Cellular Cardiology.
- (Jul 2010). "The miR-144/451 locus is required for erythroid homeostasis". The Journal of Experimental Medicine.
- (2011). "MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus". PLOS ONE.
- (Apr 2010). "MicroRNAs as a target for novel antipsychotics: a systematic review of an emerging field". The International Journal of Neuropsychopharmacology.
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about MiR-144 — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report